NanoViricides

Yahoo Finance • 2 years ago

NanoViricides shares soar 41% after announcing plans to develop a monkeypox treatment

Shares of NanoViricides Inc. jumped 41.8% in premarket trading on Thursday after the company said it began developing a monkeypox treatment. There are currently no approved or authorized therapies for monkeypox, though the Food and Drug Ad... Full story

Mentioned:

• GSPC
• SIGA